BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 953 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $894 | +140.3% | 23,694 | +190.0% | 0.14% | +291.4% |
Q2 2023 | $372 | -83.8% | 8,170 | -85.5% | 0.04% | -92.8% |
Q1 2023 | $2,292 | +46.6% | 56,516 | +84.2% | 0.48% | +62.6% |
Q4 2022 | $1,563 | -99.9% | 30,674 | +5.3% | 0.30% | +13.8% |
Q3 2022 | $1,569,000 | +376.9% | 29,136 | +467.7% | 0.26% | +422.0% |
Q2 2022 | $329,000 | -57.2% | 5,132 | -48.3% | 0.05% | -39.8% |
Q1 2022 | $769,000 | -61.1% | 9,922 | -57.0% | 0.08% | -70.1% |
Q4 2021 | $1,978,000 | +140.0% | 23,051 | +125.2% | 0.28% | +275.7% |
Q2 2021 | $824,000 | -83.4% | 10,237 | -82.7% | 0.07% | -82.4% |
Q1 2021 | $4,977,000 | +37.4% | 59,020 | +40.2% | 0.42% | +13.2% |
Q2 2020 | $3,623,000 | +48.7% | 42,089 | +41.5% | 0.37% | +291.6% |
Q2 2019 | $2,436,000 | -29.8% | 29,755 | -33.9% | 0.10% | -22.1% |
Q3 2018 | $3,469,000 | +94.2% | 45,000 | +86.0% | 0.12% | +229.7% |
Q2 2018 | $1,786,000 | -89.5% | 24,200 | -92.6% | 0.04% | -85.7% |
Q1 2017 | $17,030,000 | +227.4% | 328,400 | +200.5% | 0.26% | +50.6% |
Q3 2016 | $5,202,000 | +87.7% | 109,300 | +78.3% | 0.17% | +33.3% |
Q2 2016 | $2,771,000 | +41.4% | 61,300 | +28.5% | 0.13% | +35.8% |
Q1 2016 | $1,959,000 | +29.1% | 47,700 | +19.8% | 0.10% | +3.3% |
Q4 2015 | $1,518,000 | -74.0% | 39,800 | -77.6% | 0.09% | -79.0% |
Q3 2015 | $5,840,000 | +6.3% | 177,800 | +126.2% | 0.44% | -47.0% |
Q2 2015 | $5,496,000 | +174.8% | 78,600 | +187.9% | 0.83% | +168.8% |
Q4 2014 | $2,000,000 | -72.7% | 27,300 | -72.6% | 0.31% | -11.7% |
Q1 2014 | $7,328,000 | – | 99,600 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |